---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-142745"
form_type: "8-K"
ticker: "AGIO"
cik: "0001439222"
company_name: "AGIOS PHARMACEUTICALS, INC."
filed_at: "2025-06-18T23:59:59+00:00"
generated_at: "2026-05-19T02:43:07.275988+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Agios shareholders elect two directors, approve 2.5M share plan increase and say-on-pay

## Summary
- Class III directors Jacqualyn A. Fouse and David Scadden elected with 45.96M and 46.20M votes for, respectively.
- Non-binding say-on-pay approved: 46.84M for, 3.02M against, 16,430 abstain.
- 2023 Stock Incentive Plan amendment approved: 31.68M for, 18.20M against (36.5% opposition), adding 2.5M authorized shares.
- Ratification of PricewaterhouseCoopers as auditor: 51.20M for, 136,734 against, 22,781 abstain.

## SEC filing metadata
- accession: 0001193125-25-142745
- form_type: 8-K
- ticker: AGIO
- cik: 0001439222
- company_name: AGIOS PHARMACEUTICALS, INC.
- filed_at: 2025-06-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439222/000119312525142745/0001193125-25-142745-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439222/000119312525142745/d943981d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-142745
- JSON: https://secwatch.observer/filing/0001193125-25-142745.json
- Plain text: https://secwatch.observer/filing/0001193125-25-142745.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.